Similar results were obtained in a glioblastoma line (U87MG) with USP5 KD and TRAIL treatment (Figure 4E), suggesting that USP5 can regulate the apoptotic response to TRAIL in resistant cell lines. This evidence concerns the gene USP5 and glioblastoma.